Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073291 · ClinicalTrials.gov registry record · NA
Intervening to Prevent Youth Access to Marijuana Phase II
A NA study of Cannabis, sponsored by Klein Buendel.
- Completed
- Registry status
- NA
- Development phase
- 448
- Enrollment target
- 2
- Study locations
NCT03073291 is a NA study of Cannabis that has completed, run by Klein Buendel. The registered enrollment target is 448 participants, above the 92-participant average among 24 other Cannabis trials with a reported enrollment target (387% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT03073291, a NA study of Cannabis, has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
- 2
- Study locations
Study Summary
The legalization of recreational marijuana use and sales in Alaska, Colorado, Oregon, and Washington State is a dramatic change in U.S. substance abuse policy that places a priority on developing regulatory and enforcement systems that prevent distribution of retail recreational marijuana to minors. Responsible marijuana vendor training, modeled after effective responsible alcoholic beverage training, has the potential to help the states prevent distribution to minors. This research will produce a responsible marijuana vendor training provided by a third party, not the cannabis industry, and test its effectiveness with retail recreational marijuana licensees and employees in Colorado, Oregon, and Washington State.
Conditions Studied
Interventions
- BEHAVIORAL Responsible Marijuana Vendor Training
Study Locations (2)
California
- Pacific Institute for Research and Evaluation - Oakland
Colorado
- Klein Buendel, Inc. - Golden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2016-06 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03073291
The ClinicalTrials.gov registry entry for NCT03073291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 448 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 92-participant average among 24 other Cannabis trials with a reported enrollment target (387% higher). The listed sponsor is Klein Buendel, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which Responsible Marijuana Vendor Training is the first listed.
NCT03073291 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Colorado.
Frequently Asked Questions
What is clinical trial NCT03073291 about?
NCT03073291 is a clinical study titled "Intervening to Prevent Youth Access to Marijuana Phase II". The legalization of recreational marijuana use and sales in Alaska, Colorado, Oregon, and Washington State is a dramatic change in U.S. substance abuse policy that places a priority on developing regulatory and enforcement systems that prevent distribution of retail recreational marijuana to minors....
What is the current status of trial NCT03073291?
This trial is currently completed. It is a NA study. The enrollment target is 448 participants. The study started on 2016-06. Estimated completion is 2019-05-31.
What conditions does trial NCT03073291 study?
This clinical trial studies the following conditions: Cannabis.
What interventions are being tested in trial NCT03073291?
The interventions under investigation include: Responsible Marijuana Vendor Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03073291?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03073291 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
RECRUITING · NA
-
Impact of Reduced Cannabis Use on Functional Outcomes (R33 Phase)
COMPLETED · NA
-
Families With Substance Use and Psychosis: A Pilot Study
COMPLETED · NA
-
Feasibility Trial of rTMS for Cannabis Use Disorder
COMPLETED · NA
-
Pain Inflammation and Cannabis in HIV
COMPLETED · NA
-
Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.